Elektra Health's menopause service is built around appointments, with prescriptions sent to a pharmacy rather than sold as a required hormone bundle. For a reader comparing costs, that means the clinical visit and the medication belong on separate lines.
The Hormone Ledger checked Elektra's public information on September 20, 2026. We did not attend an appointment or verify an individual insurance benefit. This review separates the published model from the personal eligibility, cost and treatment questions that still need answers.
In this entry
Establish that you can book clinical care
Elektra offers both clinician visits and coaching. Its FAQ limits clinical care to selected states while describing broader access to nonclinical coaching. Check the service available where you will physically be during an appointment. Access to education or a coach should not be read as confirmation that a clinician can prescribe for you there.
Start your comparison with a specific goal. If you want a medical assessment of hot flashes, ask for the appropriate clinical appointment. If you want help applying a plan already agreed with a clinician, ask what coaching adds and whether it has a separate cost. These conversations can be complementary without being interchangeable.
Put three figures in your estimate
The published cash prices are $249 for an initial clinical visit and $149 for follow-up. A simple example with one of each is therefore $398 in visit fees, before medicines or other costs. That example is arithmetic, not a prediction that everyone will need exactly two visits or that insured patients pay those amounts.
Next obtain a pharmacy quote for the proposed prescription. Finally, ask about any testing, coaching or extra visits relevant to your plan. Enter only confirmed amounts into the cost worksheet; leave an unknown visible rather than entering zero and making the total look complete.
The same method makes comparisons with Midi or MyMenopauseRx more useful. Keep the time period consistent. An initial assessment alone is a different purchase from an assessment, prescription supply and follow-up over several months.
Verify coverage for the appointment date
Elektra lists several insurance relationships, but eligibility varies by plan and location. Its current FAQ announces departure from Healthfirst's network on September 30, 2026. Someone booking around that date should confirm the treatment-date benefit directly rather than relying on an older insurer listing.
The insurance explainer says medicines cost extra and notes that a plan may require a referral. Ask your insurer about the named clinician, specialist telehealth cost sharing and referral requirements. Ask the pharmacy separately about the drug benefit. A paid claim for a visit does not establish that the prescription will be covered on the same terms.
Know what the prescribing model means
Elektra describes FDA-approved hormonal and nonhormonal prescriptions, with pharmacy choice. This can make it easier to compare dispensing options for an exact product. It does not make prescribing automatic or establish that a medicine is appropriate simply because it is on the provider's website.
Before accepting a plan, record the medicine's name, route, purpose and review arrangements. The prescription-reading guide helps you organize those details. If surgery has changed your reproductive anatomy, bring the records described in hysterectomy and HRT options, rather than relying on a broad surgery checkbox.
Decide who handles each follow-up task
Elektra says its virtual care complements local care. That is a reason to agree in advance who will perform any needed examination and how information will reach your regular clinician. Ask whether you receive a visit summary and who is responsible for following up an outside test result.
Also ask how a pharmacy problem is handled. A missing refill authorization, an insurance rejection and an out-of-stock medicine require different responses. The refill and pharmacy checklist can help you describe the issue accurately instead of sending a vague message that your HRT is unavailable.
What would make this model useful for you?
Our editorial view is that Elektra warrants comparison when clinical availability, pharmacy choice and your coverage align. A reader who already has a prescriber may instead be comparing dispensing costs, where The HRT Club is a separate type of service. Someone seeking only vaginal-symptom treatment can also examine Interlude.
Do not judge the model only by the first booking. Ask what happens if the initial treatment helps partly, causes an unwanted effect or needs an in-person assessment. Use the treatment review timeline to make those questions concrete. The published information supports a comparison of service arrangements; it does not prove superior clinical outcomes or tell us how your own visit will go.
CHECK THE ORIGINAL
The source record
Provider pages document their own offers. Medical and regulatory sources provide treatment context. This is not a record of personal patient testing. All sources checked September 20, 2026.